Submitted by Anonymous (not verified) on 23 April 2025 - 11:00
Human medicines European public assessment report (EPAR): Zinplava, bezlotoxumab, Date of authorisation: 18/01/2017, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Zinplava, bezlotoxumab, Date of authorisation: 18/01/2017, Revision: 13, Status: Authorised